homeodomain-interacting protein kinase 2; hHIPk2 (HIPK2)
Jump to navigation
Jump to search
Function
- serine/threonine protein kinase with role in
- transcription regulation
- p53/TP53-mediated cellular apoptosis
- regulation of the cell cycle
- acts as a corepressor of several transcription factors, including
- SMAD1
- POU4F1/Brn3a
- probably NK homeodomain transcription factors
- phosphorylates PDX1, ATF1, PML, p53/TP53, CREB1, CTBP1, CBX4, RUNX1, EP300, CTNNB1, HMGA1 & ZBTB4
- inhibits cell growth & promotes apoptosis through the activation of p53/TP53 both at the transcription level & at the protein level (by phosphorylation & indirect acetylation)
- phosphorylation of p53/TP53 may be mediated by a p53/TP53-HIPK2-AXIN1 complex
- role in the response to hypoxia by acting as a transcriptional co-suppressor of HIF1A
- mediates transcriptional activation of TP73
- in response to TGFB, cooperates with DAXX to activate JNK
- negative regulator through phosphorylation & subsequent proteasomal degradation of CTNNB1 & the antiapoptotic factor CTBP1
- in the Wnt/beta-catenin signaling pathway acts as an intermediate kinase between TAK1 & NLK to promote proteasomal degradation of MYB
- phosphorylates CBX4 upon DNA damage & promotes its E3 SUMO-protein ligase activity
- activates CREB1 & ATF1 transcription factors by phosphorylation in response to genotoxic stress
- in response to DNA damage, stabilizes PML by phosphorylation
- PML, HIPK2 & FBXO3 may act synergically to activate p53/TP53-dependent transactivation
- promotes angiogenesis, & is involved in erythroid differentiation, especially during fetal liver erythropoiesis
- phosphorylation of RUNX1 & EP300 stimulates EP300 transcription regulation activity
- triggers ZBTB4 protein degradation in response to DNA damage
- modulates HMGA1 DNA-binding affinity
- in response to high glucose, triggers phosphorylation- mediated subnuclear localization shifting of PDX1
- role in regulation of eye size, lens formation & retinal lamination during late embryogenesis
- phosphorylated on Tyr (putative)
- autophosphorylated
- sumoylated
- when conjugated, HIPK2 is directed to nuclear speckles
- desumoylated by SENP1 (putative)
- sumoylation on Lys-32 is promoted by the E3 SUMO-protein ligase CBX4
- ubiquitinated by FBXO3, WSB1 & SIAH1, leading to rapid proteasome-dependent degradation
- degradation mediated by FBXO3, but not ubiquitination, is prevented in the presence of PML
- degradation mediated by WSB1 & SIAH1 is reversibly reduced upon DNA damage
- unstable in unstressed cells but stabilized upon DNA damage
- cleaved at Asp-923 & Asp-984 by CASP6 (p53/TP53-dependent)
- the cleaved form lacks the autoinhibitory C-terminal domain (AID), resulting in a hyperactive kinase, which potentiates p53/TP53 Ser-46 phosphorylation & subsequent activation of the cell death machinery
- interacts with CREB1, SIAH1, WSB1, CBX4, TRADD, p53/TP53, TP73, TP63, CREBBP, DAXX, P53DINP1, SKI, SMAD1, SMAD2 & SMAD3, but not SMAD4
- interacts with ATF1, PML, RUNX1, EP300, NKX1-2, NKX2-5, SPN/CD43, UBE2I, HMGA1, CTBP1, AXIN1, NLK, MYB, POU4F1, POU4F2, POU4F3, UBE2I, UBL1 & ZBTB4
- probably part of a complex consisting of p53/TP53, HIPK2 & AXIN1
Structure
- belongs to the protein kinase superfamily, CMGC Ser/Thr protein kinase family, HIPK subfamily
- contains 1 protein kinase domain
Compartment
- nucleus, PML body, cytoplasm
- concentrated in PML/POD/ND10 nuclear bodies
- small amounts are cytoplasmic
Alternative splicing
named isoforms=3
Expression
- highly expressed in heart, muscle & kidney
- weakly expression is ubiquitous
- down-regulated in several thyroid & breast tumors
- induced by UV irradiation & other genotoxic agents (adriamycin ADR, cisplatin CDDP, etoposide, IR, roscovitin), thus triggering p53/TP53 apoptotic response
- constitutively negatively regulated by SIAH1 & WSB1 through proteasomal degradation
- negative regulation is impaired upon genotoxic stress
- repressed upon hypoxia (often associated with tumors), through MDM2- (an E3 ubiquitin ligases) mediated proteasomal degradation, thus inactivating p53/TP53 apoptotic response
- hypoxia repression is reversed by Zn+2
- stabilization mediated by DNA damage requires the damage checkpoint kinases ATM & ATR
Notes
- ref[2] discusses HIPK2 & implications for cancer therapy
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/Q9H2X6.html
- ↑ 2.0 2.1 Puca R et al Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene. 2010 Aug 5;29(31):4378-87. Epub 2010 May 31 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20514025